Group 1 - KeyBanc analyst Aleksey Yefremov initiated coverage on Avient Corporation (AVNT) with an Overweight rating and a price target of $48, while shares closed at $35.77 [5] - Barclays analyst Etzer Darout initiated coverage on Protagonist Therapeutics, Inc. (PTGX) with an Overweight rating and a price target of $72, with shares closing at $58.59 [5] - Citigroup analyst Samantha Semenkow initiated coverage on Biohaven Ltd. (BHVN) with a Buy rating and a price target of $28, while shares closed at $13.49 [5] - Barclays analyst Etzer Darout also initiated coverage on Summit Therapeutics Inc. (SMMT) with an Underweight rating and a price target of $13, with shares closing at $18.12 [5] - Bernstein analyst Zhihan Ma initiated coverage on Five Below, Inc. (FIVE) with a Market Perform rating and a price target of $160, while shares closed at $149.06 [5]

Core Viewpoint - A class action securities lawsuit has been filed against Fly-E Group, Inc. for alleged securities fraud affecting investors between July 15, 2025, and August 14, 2025 [2][3]. Group 1: Lawsuit Details - The lawsuit aims to recover losses for investors who were misled by false statements regarding the company's revenue outlook and sales projections [2][3]. - Defendants allegedly created a false impression of reliable information about Fly-E's projected revenue, while the actual demand for its electric vehicle (EV) products fell short [3]. - The complaint highlights that the defendants downplayed risks associated with lithium battery supply chains, regulatory environments, and demand fluctuations for Fly-E's E-Bikes and E-Scooters [3]. Group 2: Investor Information - Investors affected by the alleged fraud have until November 7, 2025, to request appointment as lead plaintiff, although participation in any recovery does not require this [4]. - Class members may be entitled to compensation without any out-of-pocket costs or fees [4]. Group 3: Legal Representation - Levi & Korsinsky, LLP has a strong track record in securities litigation, having secured hundreds of millions for shareholders over the past 20 years [5]. - The firm has been recognized in ISS Securities Class Action Services' Top 50 Report for seven consecutive years as a leading securities litigation firm in the U.S. [5].

Core Viewpoint - A class action securities lawsuit has been filed against Replimune Group, Inc. due to alleged securities fraud affecting investors between November 22, 2024, and July 21, 2025 [1][2]. Group 1: Lawsuit Details - The lawsuit claims that defendants made false statements regarding the IGNYTE trial, overstating its prospects despite known material issues, leading to the FDA deeming the trial inadequate [3]. - Defendants' statements about Replimune's business and operations were allegedly materially false and misleading, lacking a reasonable basis during the relevant time [3]. Group 2: Investor Information - Investors who suffered losses during the specified timeframe have until September 22, 2025, to request appointment as lead plaintiff, although participation does not require this role [4]. - Class members may be entitled to compensation without any out-of-pocket costs or fees [4]. Group 3: Legal Firm Background - Levi & Korsinsky, LLP has a history of securing hundreds of millions of dollars for shareholders and is recognized as one of the top securities litigation firms in the U.S. [5].

Core Viewpoint - A class action securities lawsuit has been filed against C3.ai, Inc. due to alleged securities fraud impacting investors between February 26, 2025, and August 8, 2025 [1][2]. Group 1: Lawsuit Details - The lawsuit claims that C3.ai's management provided misleading positive statements while concealing adverse facts about the company's growth, particularly regarding the health of its CEO and its impact on deal closures [2]. - On August 8, 2025, C3.ai announced disappointing preliminary financial results for Q1 of fiscal 2026 and reduced its revenue guidance for the full fiscal year 2026, attributing these issues to "the reorganization with new leadership" and the CEO's health [2]. - Following the announcement, C3.ai's stock price dropped from $22.13 per share on August 8, 2025, to $16.47 per share on August 11, 2025, marking a decline of approximately 25.58% in just one day [2]. Group 2: Next Steps for Investors - Investors who suffered losses during the specified timeframe have until October 21, 2025, to request appointment as lead plaintiff, although participation in any recovery does not require serving as a lead plaintiff [3]. - Class members may be entitled to compensation without any out-of-pocket costs or fees, with no obligation to participate [3]. Group 3: Firm Background - Levi & Korsinsky, LLP has a history of securing hundreds of millions of dollars for shareholders and has been recognized as one of the top securities litigation firms in the United States for seven consecutive years [4].

Core Viewpoint - A class action securities lawsuit has been filed against Unicycive Therapeutics, Inc. due to alleged securities fraud affecting investors between March 29, 2024, and June 27, 2025 [1][2]. Group 1: Lawsuit Details - The lawsuit claims that Unicycive Therapeutics made false statements regarding its ability to meet FDA manufacturing compliance requirements, overstating its readiness [3]. - It is alleged that the regulatory prospects of the oxylanthanum carbonate new drug application were also overstated, leading to materially false and misleading public statements [3]. Group 2: Investor Information - Investors who suffered losses during the specified timeframe have until October 14, 2025, to request to be appointed as lead plaintiff, although participation does not require this [4]. - Class members may be entitled to compensation without any out-of-pocket costs or fees [4]. Group 3: Legal Firm Background - Levi & Korsinsky, LLP has a history of securing hundreds of millions of dollars for shareholders and is recognized as one of the top securities litigation firms in the United States [5].

Core Viewpoint - Nutex Health Inc. is facing a class action securities lawsuit due to alleged securities fraud that occurred between August 8, 2024, and August 14, 2025 [2][3]. Group 1: Lawsuit Details - The lawsuit claims that Nutex Health Inc. made false statements and concealed information regarding its third-party vendor HaloMD, which allegedly engaged in fraudulent activities to defraud insurance companies [3]. - It is alleged that the revenues from Nutex's engagement with HaloMD were unsustainable due to the fraudulent nature of the conduct [3]. - The company is accused of overstating its remediation efforts regarding material weaknesses in its internal controls over financial reporting [3]. - Nutex reportedly failed to properly account for stock-based compensation obligations, misclassifying them as equity instead of liabilities [3]. - The lawsuit suggests that these issues increased the risk of Nutex being unable to file financial reports with the SEC in a timely manner [3]. - Overall, the lawsuit asserts that Nutex's business and financial prospects were overstated, leading to materially false and misleading public statements [3]. Group 2: Next Steps for Investors - Investors who suffered losses during the specified timeframe have until October 21, 2025, to request to be appointed as lead plaintiff in the lawsuit [4]. - Participation in the lawsuit does not require any out-of-pocket costs or fees for class members [4]. Group 3: Legal Representation - Levi & Korsinsky, LLP has a strong track record in securities litigation, having secured hundreds of millions of dollars for shareholders over the past 20 years [5]. - The firm has been recognized as one of the top securities litigation firms in the United States for seven consecutive years [5].

Core Viewpoint - A class action securities lawsuit has been filed against Charter Communications, Inc. alleging securities fraud affecting investors who acquired Charter securities between July 26, 2024, and July 24, 2025 [1][2]. Group 1: Lawsuit Details - The lawsuit aims to recover losses for investors adversely affected by alleged securities fraud during the specified period [2]. - The complaint claims that the defendants made false statements and concealed the material impact of the Affordable Connectivity Program (ACP) ending, which affected Internet customer declines and revenue [3]. - It is alleged that the company failed to manage the impact of the ACP ending and did not execute broader operations effectively to compensate for the resulting declines [3]. Group 2: Implications for Investors - Investors who suffered losses during the relevant timeframe have until October 14, 2025, to request appointment as lead plaintiff, although participation does not require serving in this role [4]. - Class members may be entitled to compensation without any out-of-pocket costs or fees [4]. Group 3: Legal Representation - Levi & Korsinsky, LLP has a strong track record in securities litigation, having secured hundreds of millions for shareholders over the past 20 years [5]. - The firm has been recognized as one of the top securities litigation firms in the United States for seven consecutive years [5].

Core Viewpoint - Tronox Holdings plc is facing a class action securities lawsuit due to alleged securities fraud that negatively impacted investors between February 12, 2025, and July 30, 2025 [1][2]. Group 1: Lawsuit Details - The lawsuit claims that Tronox provided overly positive statements while concealing material adverse facts about its commercial division and forecasting processes, which ultimately led to a decline in sales and increased costs [2]. - On July 30, 2025, Tronox reported a significant reduction in TiO2 sales for the second quarter, attributing the decline to a softer coatings season and heightened competition, leading to a lowered financial outlook and a 60% reduction in dividends [2]. - Following the announcement, Tronox's stock price plummeted from $5.14 per share to $3.19 per share, marking a decline of approximately 38% in just one day [2]. Group 2: Next Steps for Investors - Investors who suffered losses during the specified timeframe have until November 3, 2025, to request appointment as lead plaintiff, although participation in any recovery does not require serving as a lead plaintiff [3]. - Class members may be entitled to compensation without any out-of-pocket costs or fees, with no obligation to participate [3]. Group 3: Firm Background - Levi & Korsinsky, LLP has a strong track record in securities litigation, having secured hundreds of millions of dollars for shareholders over the past 20 years and consistently ranking among the top securities litigation firms in the United States [4].

Core Viewpoint - Nutex Health Inc. is facing allegations of issuing materially false and misleading statements during the class period from August 8, 2024, to August 14, 2025, related to its financial reporting and business practices [1]. Group 1: Allegations Against Nutex Health Inc. - The complaint alleges that Nutex's third-party vendor, HaloMD, engaged in fraudulent activities to defraud insurance companies, leading to unsustainable revenue [1]. - Nutex is accused of overstating its remediation efforts regarding material weaknesses in its internal controls over financial reporting [1]. - The company improperly classified stock-based compensation obligations as equity instead of liabilities, increasing the risk of delayed financial report filings with the SEC [1]. Group 2: Class Action Details - Shareholders who purchased shares of Nutex during the specified class period are encouraged to register for the class action, with a deadline of October 21, 2025, to seek lead plaintiff status [2]. - Registered shareholders will receive updates through a portfolio monitoring software throughout the lifecycle of the case [2]. - Participation in the case incurs no cost or obligation for shareholders [2]. Group 3: Law Firm's Commitment - The Gross Law Firm aims to protect investors' rights against deceit and fraud, ensuring companies adhere to responsible business practices [3]. - The firm seeks recovery for investors who suffered losses due to misleading statements or omissions that inflated stock prices [3].

Core Viewpoint - The Gross Law Firm has issued a notice to shareholders of PubMatic, Inc. regarding a class action lawsuit due to alleged misleading statements and omissions that affected the company's stock value during a specified period [1][2]. Group 1: Allegations and Impact - The class period for the allegations is from February 27, 2025, to August 11, 2025 [2]. - Allegations include that a major demand side platform buyer shifted clients to a new platform, leading to a reduction in ad spend and revenue for PubMatic [2]. - The complaint asserts that the defendants made materially false and misleading statements about the company's business and prospects, lacking a reasonable basis [2]. Group 2: Shareholder Actions - Shareholders are encouraged to register for the class action by the deadline of October 20, 2025, to potentially be appointed as lead plaintiffs [3]. - Once registered, shareholders will receive updates through a portfolio monitoring software regarding the case's status [3]. Group 3: Law Firm's Mission - The Gross Law Firm aims to protect investors' rights and seeks recovery for those who suffered losses due to deceitful practices by companies [4]. - The firm emphasizes the importance of responsible business practices and corporate citizenship [4].